Exosomes Containing Glycoprotein 350 Released by EBV-Transformed B Cells Selectively Target B Cells through CD21 and Block EBV Infection In Vitro

MLA

Qin Li, et al. “Exosomes Containing Glycoprotein 350 Released by EBV-Transformed B Cells Selectively Target B Cells through CD21 and Block EBV Infection In Vitro.” The Journal of Immunology, vol. 186, Jan. 2011, pp. 73–82. EBSCOhost, https://doi.org/10.4049/jimmunol.1001145.

APA

Qin Li, Annika Scheynius, Sara M. Johansson, Noémi Nagy, Helen Vallhov, Cindy Gutzeit, Susanne Gabrielsson, Mandira Paul, Eva Klein, Sherree Friend, & Thaddeus C. George. (2011). Exosomes Containing Glycoprotein 350 Released by EBV-Transformed B Cells Selectively Target B Cells through CD21 and Block EBV Infection In Vitro. The Journal of Immunology, 186, 73–82. https://doi.org/10.4049/jimmunol.1001145

Chicago

Qin Li, Annika Scheynius, Sara M. Johansson, Noémi Nagy, Helen Vallhov, Cindy Gutzeit, Susanne Gabrielsson, et al. 2011. “Exosomes Containing Glycoprotein 350 Released by EBV-Transformed B Cells Selectively Target B Cells through CD21 and Block EBV Infection In Vitro.” The Journal of Immunology 186 (January): 73–82. doi:10.4049/jimmunol.1001145.